Healthcare investment is entering a period where AI, drug discovery, precision medicine and data are converging with the need to increase healthcare capacity and productivity. At the same time, ageing populations and rising healthcare expenditure are creating structural demand for new models of care.
The panel will examine which healthcare technologies are reaching commercial scale, where private capital can accelerate growth, and how investors are balancing long development cycles with opportunities in healthcare services and infrastructure.
